Publications by authors named "James D Ham"

Claim this Profile
S
Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice.
Fuguo Liu, Mubin Tarannum, Yingjie Zhao, Yiming J Zhang, James Dongjoo Ham

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.
Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, Grace Birch, Yasmin Z Abdulhamid, James Dongjoo Ham

Sci Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia.
Yunpeng Liu-Lupo, James Dongjoo Ham, Swarna K A Jeewajee, Lan Nguyen, Toni Delorey

Blood Cancer J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
Han Dong, James Dongjoo Ham, Guangan Hu, Guozhu Xie, Juliana Vergara, Yasmin Abdulhamid

Proc Natl Acad Sci U S A· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125.
Christopher C Fraser, Bin Jia, Guangan Hu, Lojain Ibrahim Al Johani, Roberta Fritz-Klaus, James Dongjoo Ham

J Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-NK cells: A promising cellular immunotherapy for cancer.
Guozhu Xie, Han Dong, Yong Liang, James Dongjoo Ham, Romee Rizwan

EBioMedicine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting.
Jason J Lohmueller, James D Ham, Michael Kvorjak, Olivera J Finn

Oncoimmunology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.
Jason J Lohmueller, Shuji Sato, Lana Popova, Isabel M Chu, Meghan A Tucker, James D Ham

Sci Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis